By: Gerald E. Finken Originally posted on Linkedin In November 2021, McKinsey & Company published an interesting article on how to boost excellence and innovation in clinical supply chains that are relevant to today’s industry practices. What I found most compelling was how a best-in-class clinical supply chain could change and adapt to accommodate decentralized clinical trials (DCTs)…
By: Gerald E. Finken Originally posted on Linkedin Being a pharmacist has always given me a unique insight into healthcare, especially as my career took me into the packaging and labeling of clinical supplies. I was always able to think about the packaging and labeling of clinical supplies from a different perspective, both as a…
By: Gerald E. Finken The introduction of decentralized clinical trials (“DCTs”) into clinical research has, in recent years, focused on the use of technology and telehealth to improve the clinical trial experience for patients. The proponents of the DCT model have heralded it, and rightly so, with improving study recruitment, providing better patient diversity, and…
Do you know how state pharmacy regulations apply to investigational drugs and why clinical trials need a central-fill pharmacy? Check out this live discussion from November 10th, and get your questions answered! Gerald Finken was joined by Jeremy Faulks, Director of Specialty Pharmacy at Thrifty White, for a live discussion on Regulations for Investigational Drugs,…
I want to make clinical trials available to everyone, everywhere by bringing the practice of pharmacy into clinical research. Believe it or not, this has never been done before. It will improve healthcare by giving people worldwide clear access to more lifesaving medicines and access to the medication experts — the pharmacist. In an interview…
Join us Live with our guest Tripp Logan, COO ESPhA, for a conversation on State Pharmacy Regulations and Decentralized Trials. The Enhanced Service Pharmacy Alliance (ESPhA) is the pharmacy industry’s only next-generation pharmacy service consulting firm. ESPhA’s mission is to foster an alliance of quality-driven, patient-focused pharmacists, pharmacies, consultants, vendors, and payer partners to collaborate…
By: Gerald E. Finken Technology changes healthcare. From the earliest vaccines and antibiotics to using artificial intelligence to predict the antibacterial function of a molecular structure and the development of CRISPR gene editing, there can be no doubt that technology has always, and will continue to always play a pivotal role in the healthcare fields…
Serial entrepreneur and CEO of RxE2, Gerald Finken, joins Coruzant Technologies for the Digital Executive podcast. He shares his secret to success, which includes lifelong learning and his determination to succeed when told no or it can’t be done. This is displayed by the innovation that he brings to clinical trials as an experienced pharmacist.
E2 Dispensing is part of the RxE2’s decentralized clinical trial research platform, which makes clinical trial enrollment possible for everyone, everywhere. Fargo, North Dakota, and London, UK July 29, 2020 — RxE2 and Newdays Pharmacy have launched the first pharmacy dispensing services for clinical drug trials in the European Union and the United Kingdom. This…
Fargo, ND, July 15, 2020 — RxE2 announced today the appointment of Tina Schlecht, Pharm. D. as the company’s Vice President of Pharmacy Operations. Tina Schlecht, Pharm. D., Vice President ofPharmacy Operations, RxE2 In this role, Dr. Schlecht will be responsible for: Onboarding new pharmacies worldwide to RxE2’s decentralized clinical research platform Overseeing the company’s…